Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crop Life ScienceNSE:CLSL -0.15%55 EV-to-EBIT is 11.57 as of Aug. 02, 2026, which is 5% above its 10-year median of 11.03. GuruFocus rates NSE:CLSL with a GF Score™ of 55/100 and a GF Value™ of ₹55.69 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 206 Agriculture companies, Crop Life Science ranks better than 52.91% on this metric.
Crop Life Science (NSE:CLSL) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Crop Life Science's Enterprise Value for the quarter that ended in Mar. 2026 was ₹1,558 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Crop Life Science's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹147 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science EV-to-EBIT Related Terms
Crop Life Science EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Crop Life Science's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Crop Life Science's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science EV-to-EBIT vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Crop Life Science's EV-to-EBIT falls into.
Crop Life Science's current Enterprise Value is ₹1,697 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Crop Life Science's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹147 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science (NSE:CLSL) has a EV-to-EBIT of 11.57 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Crop Life Science and its competitors. This is near median its historical median of 11.03. Over the past decade, Crop Life Science's EV-to-EBIT has ranged from 8.94 to 12.88. According to the industry distribution chart, Crop Life Science ranks #97 out of 206 companies in the Agriculture industry, placing it in the top 47.1%.
Is Crop Life Science's EV-to-EBIT too high?
Crop Life Science's current EV-to-EBIT of 11.57 is near median its 10-year median of 11.03. Over the past 10 years, this metric has ranged from a low of 8.94 to a high of 12.88. The Agriculture industry median EV-to-EBIT is 12.08. Crop Life Science's value of 11.57 is 4.2% below this industry median. Based on the distribution chart, Crop Life Science ranks #97 out of 206 companies in the Agriculture industry, which is above the industry midpoint. Overall, Crop Life Science has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's EV-to-EBIT compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #97 out of 206 companies for EV-to-EBIT. This puts Crop Life Science in the upper half of its industry. The industry median EV-to-EBIT is 12.08. Crop Life Science's value of 11.57 is 4.2% below this benchmark. Historically, Crop Life Science's own EV-to-EBIT has ranged from 8.94 to 12.88 over the past decade. While the company's 10-year median is 11.03 vs. the industry median of 12.08, Crop Life Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Agriculture company?
The median EV-to-EBIT among Agriculture companies is 12.08, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current EV-to-EBIT of 11.57 is 4.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median EV-to-EBIT is 12.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current EV-to-EBIT is 11.57, which is near median its own 10-year median of 11.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.69, compared to a current price of ₹65.90 — trading 18.3% above its estimated fair value. The current EV-to-EBIT is 11.57, which is near median its 10-year median of 11.03 and 4.2% below the Agriculture industry median of 12.08. Crop Life Science's overall GF Score™ is 55/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current EV-to-EBIT is 11.57 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued.
The current stock price of ₹65.90 is trading 18.3% above its estimated GF Value™ of ₹55.69.
GuruFocus considers Crop Life Science to be Modestly Overvalued.
Key valuation signals for NSE:CLSL:
EV-to-EBIT: 11.57 (near median its 10-year median of 11.03)
GF Value™: ₹55.69 vs. price of ₹65.90 (18.3% above fair value)
Industry Position: 4.2% below the Agriculture median (#97 of 206)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
55GF Score
Get the complete analysis for NSE:CLSL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
